Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1871 |
GBR 12935 dihydrochloride
GBR12935,GBR-12935,GBR 12935 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
GBR 12935 dihydrochloride (GBR 12935) 是一种多巴胺再吸收抑制剂。 | |||
T1871L |
GBR 12935
GBR-12935 free base,GBR12935,GBR-12935 |
||
GBR-12935 is a piperazine derivative. It is an effective and selective dopamine reuptake inhibitor. GBR-12935 is now widely used in animal research into Parkinson's disease and the dopamine pathways in the brain. | |||
T70914 |
GBR-12935 maleate
|
||
GBR-12935 is a potent and selective dopamine reuptake inhibitor. It was originally developed in its 3H radiolabelled form for the purpose of mapping the distribution of dopaminergic neurons in the brain by selective labelling of dopamine transporter proteins. This has led to potential clinical uses in the diagnosis of Parkinson's disease, although selective radioligands such as Ioflupane (¹²³I) are now available for this application. GBR-12935 is now widely used in animal research into Parkin... |